Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine binding site is a critical modulatory site on the NMDA receptor, an ionotropic glutamate receptor. It is located on the GluN1 subunit and requires glycine (or D-serine) binding for receptor activation in conjunction with glutamate. Activation of the NMDA receptor allows Ca²⁺ influx, which triggers downstream signaling essential for synaptic plasticity, learning, memory formation, and neurodevelopment. Dysregulation at this site has been implicated in neurological disorders such as schizophrenia and neurodegenerative diseases.
Agonist: Binds to the glycine binding site on the GluN1 subunit, enabling NMDA receptor activation upon glutamate binding and subsequent calcium influx. Antagonist: Competitively inhibits glycine binding, preventing NMDA receptor activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine Binding Site of N-methyl-D-aspartate Receptor.